The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
EphB-Mediated Degradation of the RhoA GEF Ephexin5 Relieves a Developmental Brake on Excitatory Synapse Formation
Open accessAbstract
The mechanisms that promote excitatory synapse formation and maturation have been extensively studied. However, the molecular events that limit excitatory synapse development so that synapses form at the right time and place and in the correct numbers are less well understood. We have identified a RhoA guanine nucleotide exchange factor, Ephexin5, which negatively regulates excitatory synapse development until EphrinB binding to the EphB receptor tyrosine kinase triggers Ephexin5 phosphorylation, ubiquitination, and degradation. The degradation of Ephexin5 promotes EphB-dependent excitatory synapse development and is mediated by Ube3A, a ubiquitin ligase that is mutated in the human cognitive disorder Angelman syndrome and duplicated in some forms of Autism Spectrum Disorders (ASDs). These findings suggest that aberrant EphB/Ephexin5 signaling during the development of synapses may contribute to the abnormal cognitive function that occurs in Angelman syndrome and, possibly, ASDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“using array tomography (AT), a powerful tool for high resolution imaging and quantification of synaptic density in vivo (Greer et al., 2010; Margolis et al., 2010; Micheva and Smith, 2007; Ross et al., 2010).”
From Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner (2012) · cites this paper as Margolis et al., 2010
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
A simple method for organotypic cultures of nervous tissue
Stoppini, L., Buchs, P., & Muller, D. (1991) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(91)90128-m · Cited by 3,096
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,992
GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors
Rossman, K. L., Der, C. J., & Sondek, J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1587 · Cited by 1,697
UBE3A/E6-AP mutations cause Angelman syndrome
Kishino, T., Lalande, M., & Wagstaff, J. E. (1997) · Nature Genetics · doi:10.1038/ng0197-70 · Cited by 1,304
Schaeren‐Wiemers, N., & Gerfin-Moser, A. (1993) · Histochemistry and Cell Biology · doi:10.1007/bf00267823 · Cited by 1,151
THE EPHRINS AND EPH RECEPTORS IN NEURAL DEVELOPMENT
Flanagan, J. G., & Vanderhaeghen, P. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.309 · Cited by 1,091
Evidence for a Role of Dendritic Filopodia in Synaptogenesis and Spine Formation
Ziv, N. E., & Smith, S. J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80283-4 · Cited by 882
Jiang, Y.-H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D., & Beaudet, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80596-6 · Cited by 852
Xia, Z., Dudek, H., Miranti, C. K., & Greenberg, M. E. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-17-05425.1996 · Cited by 787
Self-citation
Research works printed but not linked: 1
- Micheva, K.D., and Smith, S.J. (2007). Array tomography: a new tool for imaging the molecular architecture and ultrastructure of neural circuits. Neuron 55, 25–36. · DOI · Paper page
Cited by
Sorted by citations
Items 101–200 of 255
Presynaptic Ube3a E3 ligase promotes synapse elimination through down-regulation of BMP signaling
Furusawa, K., Ishii, K., Tsuji, M., Tokumitsu, N., Hasegawa, E., & Emoto, K. (2023) · Science · doi:10.1126/science.ade8978 · Cited by 41
Tiam1 is Critical for Glutamatergic Synapse Structure and Function in the Hippocampus
Rao, S., Kay, Y., & Herring, B. E. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1566-19.2019 · Cited by 35
The ubiquitin proteasome pathway in neuropsychiatric disorders
Cheon, S., Dean, M., & Chahrour, M. H. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.01.012 · Cited by 34
The role of E3 ubiquitin ligases in synapse function in the healthy and diseased brain
Kawabe, H., & Stegmüller, J. (2021) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2021.103602 · Cited by 33
HECT‐type E3 ubiquitin ligases in nerve cell development and synapse physiology
Ambrozkiewicz, M. C., & Kawabe, H. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.05.009 · Cited by 31
Ephrin-B3 coordinates timed axon targeting and amygdala spinogenesis for innate fear behaviour
Zhu, X.-N., Liu, X.-D., Sun, S., Zhuang, H., Yang, J., Henkemeyer, M. J., & Xu, N. (2016) · Nature Communications · doi:10.1038/ncomms11096 · Cited by 34
Dosage-sensitive genes in autism spectrum disorders: From neurobiology to therapy
Javed, S., Selliah, T., Lee, Y., & Huang, W. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.08.009 · Cited by 32
Rac-maninoff and Rho-vel: The symphony of Rho-GTPase signaling at excitatory synapses
Duman, J. G., Blanco, F. A., Cronkite, C. A., Ru, Q., Erikson, K., Mulherkar, S. A., Saifullah, A. B., Firozi, K., & Tolias, K. F. (2021) · Small GTPases · doi:10.1080/21541248.2021.1885264 · Cited by 35
Inhibiting proBDNF to mature BDNF conversion leads to ASD-like phenotypes in vivo
Yang, F., You, H., Mizui, T., Ishikawa, Y., Takao, K., Miyakawa, T., Li, X., Bai, T., Xia, K., Zhang, L., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02595-5 · Cited by 38
Activity-dependent changes in MAPK activation in the Angelman Syndrome mouse modelPreprint
Filonova, I., Trotter, J. H., Banko, J. L., & Weeber, E. J. (2014) · Learning & Memory · doi:10.1101/lm.032375.113 · Cited by 30
North, H. A., Clifford, M. A., & Donoghue, M. J. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs183 · Cited by 29
Park, H., Yang, J., Kim, R., Li, Y., Lee, Y., Lee, C., Park, J., Lee, D., Kim, H., & Kim, E. (2015) · Scientific Reports · doi:10.1038/srep16410 · Cited by 30
FYN is required for ARHGEF16 to promote proliferation and migration in colon cancer cells
Yu, B., Xu, L., Chen, L., Wang, Y., Jiang, H., Wang, Y., Yan, Y., Luo, S., & Zhai, Z. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02830-1 · Cited by 29
Bertling, E., & Hotulainen, P. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.05.002 · Cited by 28
The prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disorders
Bailus, B. J., & Segal, D. J. (2014) · BMC Neuroscience · doi:10.1186/1471-2202-15-76 · Cited by 28
Lee, J., Park, B., Kim, G., Kim, K.-W., Pak, J., Kim, K., Ye, M. B., Park, S., & Park, D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.07.006 · Cited by 30
UBE3A regulates the transcription of IRF, an antiviral immunity
Furumai, R., Tamada, K., Liu, X., & Takumi, T. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz019 · Cited by 26
HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome
Wang, T., Wang, J., Wang, J., Mao, L., Tang, B., Vanderklish, P. W., Liao, X., Xiong, Z., & Liao, L. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104585 · Cited by 26
Sell, G. L., Xin, W., Cook, E. K., Zbinden, M. A., Schaffer, T., O’Meally, R. N., Cole, R. N., Bonci, A., & Margolis, S. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-97898-w · Cited by 26
Self-citationThe neurobiology of mouse models syntenic to human chromosome 15q
Takumi, T. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9088-1 · Cited by 24
Harada, K., Negishi, M., & Katoh, H. (2015) · Journal of Cell Science · doi:10.1242/jcs.163790 · Cited by 25
Association of Genetic Variants on 15q12 With Cortical Thickness and Cognition in Schizophrenia
Bakken, T. E. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.81 · Cited by 25
Potential therapeutic approaches for Angelman syndrome
Bi, X., Sun, J., Ji, A. X., & Baudry, M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1115837 · Cited by 27
Humphries, B. A., Wang, Z., & Yang, C. (2020) · Cancers · doi:10.3390/cancers12051092 · Cited by 26
Paradoxes of the EphB1 receptor in malignant brain tumors
Wei, W., Wang, H., & Ji, S. (2017) · Cancer Cell International · doi:10.1186/s12935-017-0384-z · Cited by 24
Enikanolaiye, A., Ruston, J., Zeng, R., Taylor, C., Schrock, M., Buchovecky, C. M., Shendure, J., Acar, E. F., & Justice, M. J. (2020) · Genome Research · doi:10.1101/gr.258400.119 · Cited by 25
Pasini, S., Liu, J., Corona, C., Pezé-Heidsieck, E., Shelanski, M. L., & Greene, L. A. (2016) · Scientific Reports · doi:10.1038/srep36952 · Cited by 22
New genes involved in Angelman syndrome-like: Expanding the genetic spectrum
Aguilera, C., Gabau, E., Ramírez-Mallafré, A., Gasca, C. B. I., Domínguez‐Carral, J., Delgadillo, V., Laurie, S., Derdak, S. V., Padilla, N., de la Cruz, X., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258766 · Cited by 28
Ube3a/E6AP is involved in a subset of MeCP2 functions
Kim, S., Chahrour, M. H., Ben‐Shachar, S., & Lim, J. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.036 · Cited by 23
Sell, G. L., Schaffer, T. B., & Margolis, S. S. (2017) · Journal of Clinical Investigation · doi:10.1172/jci85504 · Cited by 25
Self-citationHistorical perspective and progress on protein ubiquitination at glutamatergic synapses
Mabb, A. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108690 · Cited by 24
E6AP in the Brain: One Protein, Dual Function, Multiple Diseases
Hokayem, J. A. E., & Nawaz, Z. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8563-y · Cited by 25
Amygdala EphB2 signaling regulates glutamatergic neuron maturation and innate fear
Zhu, X.-N., Liu, X.-D., Zhuang, H., Henkemeyer, M., Yang, J.-Y., & Xu, N.-J. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0845-16.2016 · Cited by 22
Vinci, M., Treccarichi, S., Rando, R. G., Musumeci, A., Todaro, V., Federico, C., Saccone, S., Elia, M., & Calı̀, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-66475-2 · Cited by 22
PKCε Inhibits Neuronal Dendritic Spine Development through Dual Phosphorylation of Ephexin5
Schaffer, T. B., Smith, J. E., Cook, E. K., Phan, T. P., & Margolis, S. S. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.005 · Cited by 23
Self-citationProtein Interaction Network Biology in Neuroscience
Basu, A., Ash, P. E. A., Wolozin, B. L., & Emili, A. (2020) · PROTEOMICS · doi:10.1002/pmic.201900311 · Cited by 23
Smit‐McBride, Z., Modjtahedi, S. P., Cessna, C. T., Telander, D. G., Hjelmeland, L. M., & Morse, L. S. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-7084 · Cited by 21
Emerging Roles of Ephexins in Physiology and Disease
Kim, K., Lee, S.-A., & Park, D. (2019) · Cells · doi:10.3390/cells8020087 · Cited by 21
Offensperger, F., Müller, F., Jansen, J., Hammler, D., Götz, K., Marx, A., Sirois, C. L., Chamberlain, S. J., Stengel, F., & Scheffner, M. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.08.017 · Cited by 21
Ambrozkiewicz, M. C., Cuthill, K. J., Harnett, D., Kawabe, H., & Tarabykin, V. S. (2020) · Cells · doi:10.3390/cells9112455 · Cited by 21
Orchestrating the synaptic network by tyrosine phosphorylation signalling
Dabrowski, A., & Umemori, H. (2011) · The Journal of Biochemistry · doi:10.1093/jb/mvr047 · Cited by 20
A dual role for the RhoGEF Ephexin5 in regulation of dendritic spine outgrowth
Hamilton, A. M., Lambert, J. T., Parajuli, L. K., Vivas, O., Park, D. K., Stein, I. S., Jahncke, J. N., Greenberg, M. E., Margolis, S. S., & Zito, K. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.02.001 · Cited by 21
Self-citationUbiquitin system mutations in neurological diseases
Zenge, C., & Ordureau, A. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.06.011 · Cited by 20
Tonazzini, I., Meucci, S., van Woerden, G. M., Elgersma, Y., & Cecchini, M. G. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201500815 · Cited by 20
Folci, A., Mirabella, F., & Fossati, M. (2020) · eNeuro · doi:10.1523/eneuro.0137-20.2020 · Cited by 22
Eph Receptors Are Involved in the Activity-Dependent Synaptic Wiring in the Mouse Cerebellar Cortex
Cesa, R., Premoselli, F., Renna, A., Ethell, I. M., Pasquale, E. B., & Strata, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019160 · Cited by 18
Lefort, R. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0328-4 · Cited by 17
The Role of RhoJ in Endothelial Cell Biology and Tumor Pathology
Shi, T., Li, G., & Xiao, H. (2016) · BioMed Research International · doi:10.1155/2016/6386412 · Cited by 18
Ruíz‐Antorán, B., Sancho‐López, A., Cazorla-Calleja, R., López-Pájaro, L. F., Leiva, Á., Escalera, G. I., Marín-Serrano, M. E., Rincón-Ortega, M., Herguedas, J. L., Rossignoli-Palomeque, T., et al. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0891-6 · Cited by 18
Angelman syndrome: advancing the research frontier of neurodevelopmental disorders
Philpot, B. D., Thompson, C. E., Franco, L., & Williams, C. A. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-010-9066-z · Cited by 17
Autism Spectrum Disorder Genes: Disease-Related Networks and Compensatory Strategies
Lim, H. K., Yoon, J. H., & Song, M. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.922840 · Cited by 18
Regional Regulation of Purkinje Cell Dendritic Spines by Integrins and Eph/Ephrins
Heintz, T. G., Eva, R., & Fawcett, J. W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158558 · Cited by 17
Kumar, V., Joshi, T., Vatsa, N., Singh, B. K., & Jana, N. R. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00289 · Cited by 18
Approaches to Manipulate Ephrin-A:EphA Forward Signaling Pathway
Baudet, S., Bécret, J., & Nicol, X. (2020) · Pharmaceuticals · doi:10.3390/ph13070140 · Cited by 17
Neuronal UBE3A substrates hold therapeutic potential for Angelman syndrome
Krzeski, J. C., Judson, M. C., & Philpot, B. D. (2024) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2024.102899 · Cited by 18
Pharmacological therapies for Angelman syndrome
Tan, W., & Bird, L. M. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-015-0408-z · Cited by 20
Towards an understanding of Angelman syndrome in mice studies
Yang, X. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24576 · Cited by 18
Türker, F., Bharadwaj, R. A., Kleinman, J. E., Weinberger, D. R., Hyde, T. M., White, C. J., Williams, D. W., & Margolis, S. S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104811 · Cited by 16
Self-citationMartinez, A., Ramírez, J., Osinalde, N., Arizmendi, J. M., & Mayor, U. (2018) · BioMed Research International · doi:10.1155/2018/3180413 · Cited by 16
Scheiffele, P., & Beg, A. A. (2010) · Nature · doi:10.1038/468907a · Cited by 15
Ding, X., Chen, Y., Guo, C., Fu, Y., Qin, C., Zhu, Q., Wang, J., Zhang, R., Tian, H., Feng, R., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02560-6 · Cited by 18
Montani, C., Balasco, L., Pagani, M., Alvino, F. G., Barsotti, N., de Guzman, A. E., Galbusera, A., Felice, A. D., Nickl‐Jockschat, T., Migliarini, S., et al. (2024) · Science Advances · doi:10.1126/sciadv.adg1421 · Cited by 16
The E3 ligase ube3a is required for learning in Drosophila melanogaster
Chakraborty, M., Paul, B. K., Nayak, T., Das, A., Jana, N. R., & Bhutani, S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.110 · Cited by 15
Transsynaptic Signaling of Ephs in Synaptic Development, Plasticity, and Disease
Washburn, H. R., Chander, P., Srikanth, K. D., & Dalva, M. B. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2022.11.030 · Cited by 13
Türker, F., Brennan, A. M., & Margolis, S. S. (2023) · Molecular Biology of the Cell · doi:10.1091/mbc.e23-06-0218 · Cited by 14
Self-citationRoy, B., Amemasor, E., Hussain, S., & Castro, K. (2023) · Diseases · doi:10.3390/diseases12010007 · Cited by 15
ARHGEF15 in Sertoli cells contributes to germ cell development and testicular immune privilege
Chen, F., Wu, Y., Ke, L., Lin, X., Wang, F., & Qin, Y. (2022) · Biology of Reproduction · doi:10.1093/biolre/ioac166 · Cited by 13
Azadiradione up-regulates the expression of parvalbumin and BDNF via Ube3a
Jana, S., Giri, B., Das, S., Manna, A., Mandal, S. C., & Jana, N. R. (2023) · Gene · doi:10.1016/j.gene.2023.148081 · Cited by 12
Unraveling the Roles of UBE3A in Neurodevelopment and Neurodegeneration
Yang, X., & Huang, Y. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052304 · Cited by 12
Double inhibition and activation mechanisms of Ephexin family RhoGEFs
Zhang, M., Lin, L., Wang, C., & Zhu, J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024465118 · Cited by 12
The ephrin receptor EphB2 regulates the connectivity and activity of enteric neurons
Bodin, R., Paillé, V., Oullier, T., Durand, T., Aubert, P., Berre‐Scoul, C. L., Hulin, P., Neunlist, M., & Cissé, M. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101300 · Cited by 14
Intermolecular steric inhibition of Ephexin4 is relieved by Elmo1
Kim, K., Lee, J., Lee, S.-A., Moon, H., Park, B., Kim, D., Joo, Y., & Park, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-04810-6 · Cited by 12
Verpelli, C., Galimberti, I., Gomez‐Mancilla, B., & Sala, C. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22093 · Cited by 14
Hu, J.-H., Malloy, C., Liu, Y., Park, J. M., Pratt, A. E., Welch, M. A., Murphy, J. G., Abebe, D. T., Karlsson, R., Cameron, H. A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115583 · Cited by 10
Ephs and ephrins: Emerging therapeutic targets in neuropathology
Attwood, B. K., Patel, S., & Pawlak, R. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.12.008 · Cited by 9
Tyrosine Phosphorylation of SGEF Regulates RhoG Activity and Cell Migration
Okuyama, Y., Umeda, K., Negishi, M., & Katoh, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159617 · Cited by 9
Loss of UBE3A impacts both neuronal and non-neuronal cells in human cerebral organoids
Estridge, R. C., Yagci, Z. B., Sen, D., Johnson, T. J., Kelkar, G. R., Ptacek, T., Simon, J. M., & Keung, A. J. (2025) · Communications Biology · doi:10.1038/s42003-025-08262-x · Cited by 10
Parcellation of the thalamus into distinct nuclei reflects EphA expression and function
Lehigh, K. M., Leonard, C. E., Baranoski, J. F., & Donoghue, M. J. (2013) · Gene Expression Patterns · doi:10.1016/j.gep.2013.08.002 · Cited by 8
Pharmacotherapeutic management of seizures in patients with Angleman Syndrome
Samanta, D. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2105141 · Cited by 8
He, L., Chen, S., Yang, Q., Wu, Z., Lao, Z.-K., Tang, C.-F., Song, J.-J., Liu, X., Lu, J., Xu, X., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2219952120 · Cited by 8
Chang, C., Banerjee, S. L., Park, S. S., Zhang, X., Cotnoir‐White, D., Opperman, K. J., Desbois, M., Grill, B. J., & Kania, A. (2023) · eLife · doi:10.7554/elife.89176 · Cited by 12
Viho, E. M. G., Punt, A. M., Distel, B., Houtman, R., Kroon, J., Elgersma, Y., & Meijer, O. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010303 · Cited by 7
Qi, L., Cui, E., Ji, C.-M., Zhang, X.-B., Wang, Z.-A., Sun, Y.-Z., Xu, J.-C., Zhai, X., Chen, Z.-J., Li, J., et al. (2019) · Europe PMC (PubMed Central) · Cited by 8
Biagioni, M., Baronchelli, F., & Fossati, M. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106669 · Cited by 7
A patogênese genética e molecular da síndrome de Angelman
Maris, A. F., & Trott, A. (2011) · Jornal Brasileiro de Psiquiatria · doi:10.1590/s0047-20852011000400014 · Cited by 8
Neurodevelopmental Underpinnings of Angelman Syndrome
Li, G. (2014) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.1000111 · Cited by 6
Preferential Control of Basal Dendritic Protrusions by EphB2
Kayser, M. S., Lee, A. C., Hruska, M., & Dalva, M. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017417 · Cited by 8
Contrasting synaptic roles of MDGA1 and MDGA2Preprint
Bemben, M. A., Sandoval, M. A., Le, A. A., Won, S., Chau, V. N., Lauterborn, J. C., Incontro, S., Li, K. H., Burlingame, A. L., Roche, K. W., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.25.542333 · Cited by 10
Rayi, P. R., & Kaphzan, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.670998 · Cited by 8
Uncovering a Role for SK2 in Angelman Syndrome
Lizarraga, S. B., & Morrow, E. M. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.009 · Cited by 6
Eph Receptor Effector Ephexin Mediates Olfactory Dendrite Targeting in Drosophila
Sardana, J., Organisti, C., & Kadow, I. C. G. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22624 · Cited by 5
` Neurodevelopmental Underpinnings of Angelman Syndrome
Qiu, G. L. S. (2014) · OMICS Journal of Radiology · doi:10.4172/2167-7964.1000111 · Cited by 5
Gaitanos, T. N., Dudanova, I., Σάκκου, Μ., Klein, R., & Paixão, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-11888-8_5 · Cited by 5
Enikanolaiye, A., Ruston, J., Zeng, R., Taylor, C., Schrock, M., Buchovecky, C. M., Shendure, J., Acar, E. F., & Justice, M. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/810929 · Cited by 5
Wilton, D. K., Mastro, K. J., Heller, M. D., Gergits, F. W., Willing, C. R., Frouin, A., Daggett, A., Gu, X., Kim, A. Y., Faull, R. L. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.03.471180 · Cited by 5
New Mechanisms Underlying Oncogenesis in Dbl Family Rho Guanine Nucleotide Exchange Factors
Ravala, S. K., & Tesmer, J. J. G. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000904 · Cited by 4
Kim, H., Jeon, Y., Kim, S., Guo, Y., Kim, D., Jang, G., Brasch, J., Um, J. W., & Ko, J. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102772 · Cited by 3
The emergence of Ephexin5 as a therapeutic target in Alzheimer’s disease
Cook, E. K., Sell, G. L., Schaffer, T. B., & Margolis, S. S. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1586884 · Cited by 3
Self-citationWang, Y.-J., Li, S., Tao, H.-P., Zhang, X., Fang, Y.-G., & Yang, Q. (2023) · Reproductive Biology · doi:10.1016/j.repbio.2022.100727 · Cited by 3
The novel insights into spatiotemporal cell biology and its schematic frame, triple W
Hou, Y., Hou, Y., He, S., & Xing, R. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22952 · Cited by 3
Metadata
- Authors
- Margolis, S. S., Salogiannis, J., Lipton, D. M., Mandel-Brehm, C., Wills, Z. P., Mardinly, A. R., Hu, L., Greer, P. L., Bikoff, J. B., Ho, H.-Y. H., Soskis, M. J., Sahin, M., & Greenberg, M. E.
- Affiliations
- Harvard University (US)
- Corresponding author
- Greenberg, Michael E.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 143
- Issue
- 3
- Pages
- 442-455
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC2967209
- OpenAlex
- W2031746153
- Cited by
- 256
- References
- 42
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 12 · 2023: 20 · 2022: 10 · 2021: 14 · 2020: 16 · 2019: 12 · 2018: 13 · 2017: 16 · 2016: 21 · 2015: 20 · 2014: 17 · 2013: 19 · 2012: 27
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1020 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01ns045500-29)
- National Institute on Aging (5T32AG00222-15, T32AG000222)
- National Institute of Neurological Disorders and Stroke (R01-NS-045500, R01 5R01NS045500)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- EphB receptors, protein degradation, ubiquitination, UBE3A, Angelman syndrome, autism spectrum disorder, synapse maturation, receptor tyrosine kinase signaling
- MeSH terms
- Animals, Child, Child Development Disorders, Pervasive, Embryo, Mammalian, Humans, Synapses, Angelman Syndrome, Dentate Gyrus, Rats, Long-Evans, rhoA GTP-Binding Protein, Receptors, Eph Family, Ubiquitin-Protein Ligases, Mice, Rats, Gene Knockout Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review